Nektar Therapeutics
NKTR
NKTR
246 hedge funds and large institutions have $2.87B invested in Nektar Therapeutics in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 65 increasing their positions, 108 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
246
Holders Change
-11
Holders Change %
-4.28%
% of All Funds
4.98%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
65
Reduced
108
Closed
32
Calls
$14.8M
Puts
$10.9M
Net Calls
+$3.93M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$41.7M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
+$8.16M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.26M |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$3.48M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.26M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$12.1M |
| 2 |
BlackRock
New York
|
-$11.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.1M |
| 4 |
Primecap Management
Pasadena,
California
|
-$8.96M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$8.29M |
